Glaucine Stats & Data
PubChem
MW355.4
FormulaC21H25NO4
LogP3.4
IUPAC(6aS)-1,2,9,10-tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline
InChIKey
RUZIUYOSRDWYQF-HNNXBMFYSA-N
Psychoactive Class
Depressant
Experience Report Analysis
Erowid
8
Reports
2009–2018
Date Range
5
With Age Data
8
Effects Detected
Demographics
Gender Distribution
Age Distribution
Reports Over Time
Effect Analysis
ErowidEffects aggregated from 8 experience reports (8 Erowid)
8
Reports
8
Effects Detected
5
Positive
1
Adverse
2
Neutral
Effect Sentiment Distribution
Confidence Distribution
Positive Effects 5
Euphoria
62.5%
70%
Sedation
62.5%
70%
Color Enhancement
50.0%
70%
Focus Enhancement
37.5%
70%
Anxiety Suppression
37.5%
70%
Adverse Effects 1
Nausea
37.5%
70%
Real-World Dose Distribution
62K DosesFrom 5 individual dose entries
Oral (n=5)
Median: 160.0mg
25th: 120.0mg
75th: 200.0mg
90th: 200.0mg
mg/kg median: 2.105
mg/kg 75th: 2.133
Form / Preparation
Most common forms and preparations reported